PRRT2 and asthma: Therefore, PKCθ and its downstream transcription factors are accountable for the control of asthma-related inflammatory responses and tissue injury [22], suggesting that standardized extracts or natural bioactive compounds targeting these signaling molecules may modulate symptoms of pulmonary inflammatory disease.